loadpatents
name:-0.035697937011719
name:-0.027542114257812
name:-0.0096199512481689
LEE; Jinhwa Patent Filings

LEE; Jinhwa

Patent Applications and Registrations

Patent applications and USPTO patent grants for LEE; Jinhwa.The latest application filed is for "imidazopyridinyl compounds and use thereof for treatment of proliferative disorders".

Company Profile
8.30.40
  • LEE; Jinhwa - Gyeonggi-do KR
  • Lee; Jinhwa - Yongin-si KR
  • Lee; Jinhwa - Giheung-gu PA KR
  • Lee; Jinhwa - Collegeville PA
  • Lee; Jinhwa - Wayne PA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Imidazopyridinyl Compounds And Use Thereof For Treatment Of Proliferative Disorders
App 20220242861 - LEE; Jinhwa ;   et al.
2022-08-04
Pharmaceutical Salts Of Benzothiazol Compounds, Polymorphs And Methods For Preparation Thereof
App 20220177463 - LEE; Jinhwa ;   et al.
2022-06-09
[18F]-Labeled Benzothiazole Derivative As PET Radiotracer
App 20220160902 - LEE; Jinhwa ;   et al.
2022-05-26
Indazoles As Hematopoietic Progenitor Kinase 1 (hpk1) Inhibitors And Methods Using Same
App 20220098193 - LEE; Jinhwa ;   et al.
2022-03-31
Indazoles As Hematopoietic Progenitor Kinase 1 (hpk1) Inhibitors And Methods Using Same
App 20220098219 - LEE; Jinhwa ;   et al.
2022-03-31
2-amino-3-carbonyl Imidazopyridine And Pyrazolopyridine Compounds
App 20220087985 - LEE; Jinhwa ;   et al.
2022-03-24
Imidazopyridinyl Compounds And Use Thereof For Treatment Of Neurodegenerative Disorders
App 20210347774 - LEE; Jinhwa ;   et al.
2021-11-11
Imidazopyridinyl compounds and use thereof for treatment of neurodegenerative disorders
Grant 11,098,044 - Lee , et al. August 24, 2
2021-08-24
Benzothiazol compounds and methods using the same for treating neurodegenerative disorders
Grant 10,968,188 - Lee , et al. April 6, 2
2021-04-06
Imidazopyridinyl Compounds And Use Thereof For Treatment Of Neurodegenerative Disorders
App 20200270246 - LEE; Jinhwa ;   et al.
2020-08-27
Benzothiazol Compounds And Methods Using The Same For Treating Neurodegenerative Disorders
App 20200270222 - LEE; Jinhwa ;   et al.
2020-08-27
Benzothiazol compounds and methods using the same for treating neurodegenerative disorders
Grant 10,669,246 - Lee , et al.
2020-06-02
Processes for preparing benzothiazol compounds and methods of using the same for treating neurodegenerative disorders
Grant 10,385,046 - Lee , et al. A
2019-08-20
Benzothiazol Compounds And Methods Using The Same For Treating Neurodegenerative Disorders
App 20190100500 - LEE; Jinhwa ;   et al.
2019-04-04
Anti-inflammation compounds
Grant 9,029,389 - No , et al. May 12, 2
2015-05-12
Thiophene derivative as SGLT2 inhibitor and pharmaceutical composition comprising same
Grant 9,006,187 - Lee , et al. April 14, 2
2015-04-14
Arylpiperazine-containing pyrrole 3-carboxamide derivatives for treating depressive disorders
Grant 8,895,558 - Lee , et al. November 25, 2
2014-11-25
Arylpiperazine-containing imidazole 4-carboxamide derivatives and pharmaceutical composition comprising same
Grant 8,835,436 - Lee , et al. September 16, 2
2014-09-16
Arylpiperazine-containing purine derivatives and uses thereof
Grant 8,785,453 - Lee , et al. July 22, 2
2014-07-22
Method for preparing 5-chloro-N-({(5S)-2-oxo-3-[4-(5,6-dihydro-4H-[1,2,4]triazin-1-yl)phenyl]-- 1,3-oxazolidin-5-yl}methyl) derivative and intermediate used therein
Grant 8,754,210 - Cho , et al. June 17, 2
2014-06-17
Anti-Inflammation Compounds
App 20140155387 - No; Zaesung ;   et al.
2014-06-05
Thiazole derivatives as SGLT2 inhibitors and pharmaceutical composition comprising same
Grant 8,586,550 - Lee , et al. November 19, 2
2013-11-19
C-aryl glucoside SGLT2 inhibitors and pharmaceutical compositions comprising same
Grant 8,541,380 - Lee , et al. September 24, 2
2013-09-24
(+)-3-hydroxymorphinan-based Polycycle Derivatives
App 20130217672 - Lee; Jinhwa ;   et al.
2013-08-22
Novel Thiophene Derivative As Sglt2 Inhibitor And Pharmaceutical Composition Comprising Same
App 20130172278 - Lee; Jinhwa ;   et al.
2013-07-04
Thiazole Derivatives as SGLT2 Inhibitors and Pharmaceutical Composition Comprising Same
App 20130090298 - Lee; Jinhwa ;   et al.
2013-04-11
Peptide Deformylase Inhibitors
App 20130045962 - Qin; Donghui ;   et al.
2013-02-21
Sulfur containing pyrazole-heterocycle derivatives as cannabinoid CB1 receptor antagonists
Grant 8,309,584 - Lee , et al. November 13, 2
2012-11-13
Arylpiperazine-containing Purine Derivatives And Uses Thereof
App 20120232090 - Lee; Jinhwa ;   et al.
2012-09-13
Method For Preparing 5-chloro-n-(methyl)thiophen-2-carboxamide Derivative And Intermediate Used Therein
App 20120136149 - Cho; Young Lag ;   et al.
2012-05-31
(+)-3-hydroxymorphinan Derivatives As Neuroprotectants
App 20120122848 - Lee; Jinhwa ;   et al.
2012-05-17
Orally bioavailable prodrugs of (+)-3-hydroxymorphinan for Parkinson'S disease prevention or treatment
Grant 8,178,551 - Lee , et al. May 15, 2
2012-05-15
Novel Arylpiperazine-containing Imidazole 4-carboxamide Derivatives And Pharmaceutical Composition Comprising Same
App 20120115881 - Lee; Jinhwa ;   et al.
2012-05-10
Novel C-aryl Glucoside Sglt2 Inhibitors And Pharmaceutical Compositions Comprising Same
App 20120101051 - Lee; Jinhwa ;   et al.
2012-04-26
Sulfur Containing Pyrazole-heterocycle Derivatives As Cannabinoid Cb1 Receptor Antagonists
App 20110178140 - Lee; Jinhwa ;   et al.
2011-07-21
Arylpiperazine-containing Pyrrole 3-carboxamide Derivatives For Treating Depressive Disorders
App 20110178091 - Lee; Jinhwa ;   et al.
2011-07-21
Peptide deformylase inhibitors
Grant 7,919,528 - Aubart , et al. April 5, 2
2011-04-05
Heteroaryl-pyrazole derivatives as cannabinoid CB1 receptor antagonists
Grant 7,875,647 - Lee , et al. January 25, 2
2011-01-25
Orally Bioavailable Products Of (+)-3-hydroxymorphinan For Parkinson's Disease Prevention Or Treatment
App 20100113500 - Lee; Jinhwa ;   et al.
2010-05-06
Peptide deformylase inhibitors
Grant 7,507,726 - Aubart , et al. March 24, 2
2009-03-24
Peptide deformylase inhibitors
Grant 7,442,793 - Lee , et al. October 28, 2
2008-10-28
Azole Derivatives as Cannabinoid CB1 Receptor Antagonists
App 20080262066 - LEE; Jinhwa ;   et al.
2008-10-23
Heteroaryl-imidazole Derivatives As Cannabinoid Cb1 Receptor Antagonists
App 20080207704 - Lee; Jinhwa ;   et al.
2008-08-28
Heteroaryl-Imidazole Derivatives as Cannabinoid CB1 Receptor Antagonists
App 20080207705 - LEE; Jinhwa ;   et al.
2008-08-28
Peptide Deformylase Inhibitors
App 20080167302 - Aubart; Kelly M. ;   et al.
2008-07-10
Peptide deformylase inhibitors
Grant 7,375,120 - Christensen, IV , et al. May 20, 2
2008-05-20
Heteroaryl-pyrazole derivatives as cannabinoid CB1 receptor antagonists
App 20080081815 - Lee; Jinhwa ;   et al.
2008-04-03
Heteroaryl-Pyrazole Derivatives as Cannabinoid CB1 Receptor Antagonists
App 20080081812 - LEE; Jinhwa ;   et al.
2008-04-03
Peptide deformylase inhibitors
App 20070173542 - Lee; Jinhwa ;   et al.
2007-07-26
Peptide deformylase inhibitors
Grant 7,166,624 - Leber , et al. January 23, 2
2007-01-23
Peptide deformylase inhibitors
App 20060229341 - Christensen; Siegfried B. IV ;   et al.
2006-10-12
Peptide deformylase inhibitors
Grant 7,019,003 - Xiang , et al. March 28, 2
2006-03-28
Peptide deformylase inhibitors
App 20060052423 - Leber; Jack Dale ;   et al.
2006-03-09
Peptide deformylase inhibitors
App 20050222412 - Aubart, Kelly M. ;   et al.
2005-10-06
Peptide deformylase inhibitors
Grant 6,797,730 - Xiang , et al. September 28, 2
2004-09-28
Peptide Deformylase Inhibitors
App 20040133001 - Xiang, Jia-Ning ;   et al.
2004-07-08
Peptide deformylase inhibitors
App 20040087585 - Xiang, Jia-Ning ;   et al.
2004-05-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed